Marinomed Biotech AG Announces New Head of Investor & Public Relations

Lucia Ziegler has been appointed as the new Head of Investor & Public Relations at Marinomed Biotech AG, starting from March 2024. This addition to the Marinomed team represents the merging of the company's Public Relations and Investor Relations into one integrated department. Ziegler, holding a Master of Science in Molecular Biology, has been with Marinomed for three years, previously focusing on Public Relations and Social Media.

With this new role, Ziegler will not only continue her PR responsibilities but also take on the IR activities, succeeding Stephanie Kniep, who remains connected with the company. The CEO of Marinomed, Andreas Grassauer, expressed his optimism about the synergy of IR and PR under one leadership, aiming for better and more efficient communications with stakeholders. Grassauer also acknowledged the significant contributions made by Stephanie Kniep in developing Marinomed's IR activities on international capital markets.